fluorodeoxyglucose f18 has been researched along with Inappropriate GH Secretion Syndrome (Acromegaly) in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maiza, JC; Revel, C | 1 |
Giubbini, R; Giustina, A; Mazziotti, G | 1 |
Balcerzyk, M; Cano, DA; Castaño, JP; Fernandez-Maza, L; Ibañez-Costa, A; Leal-Campanario, R; Leal-Cerro, A; Luque, RM; Martín-Rodríguez, JF; Muñoz-Bravo, JL; Soto-Moreno, A; Venegas-Moreno, E | 1 |
Maiza, JC; Revel, C; Schneebeli, S; Zunic, P | 1 |
Hasegawa, S; Hirata, M; Hori, M; Nishimura, T; Tokita, N; Yamaguchi, H; Yoshioka, J | 1 |
5 other study(ies) available for fluorodeoxyglucose f18 and Inappropriate GH Secretion Syndrome (Acromegaly)
Article | Year |
---|---|
Evolution of (18)FDG pituitary uptake after medical control of acromegaly.
Topics: Acromegaly; Adenoma; Fluorodeoxyglucose F18; Hormone Antagonists; Humans; Pituitary Gland; Pituitary Neoplasms; Plasmacytoma; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin | 2014 |
Molecular imaging in acromegaly: should clinicians look carefully at developments in the field?
Topics: Acromegaly; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly.
Topics: Acromegaly; Animals; Cell Cycle; Cellular Senescence; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Growth Hormone; Growth Hormone-Secreting Pituitary Adenoma; Phenotype; Positron-Emission Tomography; Rats; Tomography, X-Ray Computed; Tumor Cells, Cultured | 2015 |
Acromegaly revealed by 18FDG-PET/CT in a plasmocytoma patient.
Topics: Acromegaly; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plasmacytoma; Positron-Emission Tomography; Radiography; Tomography, Emission-Computed | 2012 |
Fluorine-18 FDG myocardial positron emission tomographic findings before and after pituitary adenoma resection in a patient with acromegalic cardiomyopathy.
Topics: Acromegaly; Adenoma; Cardiac Output, Low; Cardiomyopathy, Hypertrophic; Fluorodeoxyglucose F18; Follow-Up Studies; Gated Blood-Pool Imaging; Glucose; Heart; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Myocardium; Pituitary Neoplasms; Preoperative Care; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Ventricular Function, Left | 2000 |